Health News
Santa Barbara Medical Innovations recently participated in the Microsoft Founder's Gala. This event is held in association with the Bill and Melinda Gates Foundation.
11:43 Jun 6, 2010
Vitiligo â€
10:20 Jun 6, 2010
Nektar Therapeutics today announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 in women with platinum-resistant/refractory ovarian cancer. A total of 68 patients were enrolled with platinum-resistant disease, ...
09:31 Jun 6, 2010
A colorful stream of 2,400 bicyclists and volunteer "roadies" from nearly every state and eight countries left San Francisco this morning on the way to Los Angeles as participants in AIDS/LifeCycle, the world's largest annual HIV/AIDS ...
09:23 Jun 6, 2010
Results of a Phase III study presented today at the American Society of Clinical Oncology Annual Meeting showed that Eisai's eribulin mesylate significantly improved median overall survival compared with Treatment of Physician's Choice in heavily ...
08:00 Jun 6, 2010
Only five months after Mercy For Animals' undercover video at Willet Dairy aired on Nightline and inspired legislation to prevent future abuses, a new Mercy For Animals dairy video has even ag professionals crying uncle.
07:34 Jun 6, 2010
Amgen today announced that AMG 386, combined with paclitaxel, demonstrated antitumor activity in a randomized Phase 2 trial involving 161 patients with recurrent ovarian cancer. The results are being presented for the first time in an oral ...
06:01 Jun 6, 2010
OXiGENE, Inc. , a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled ...
06:00 Jun 6, 2010
Genentech, Inc., a wholly owned member of the Roche Group, today announced results from a Phase III study of Avastin that showed women with previously untreated advanced ovarian cancer who received Avastin in combination with chemotherapy, followed ...
06:00 Jun 6, 2010
Focusing on helping clinicians improve experiences for their patients, GE Healthcare is highlighting an innovative portfolio of molecular imaging technologies and agents at the 57th annual meeting of the Society of Nuclear Medicine , June 5-9, in ...
06:00 Jun 6, 2010
Genta Incorporated announced today the presentation of combined data on early endpoints from the Company's randomized Phase 3 trials of Genasense Injection plus chemotherapy in patients with advanced melanoma. The presentation included a 'pooled ...
05:10 Jun 6, 2010
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular ...
05:01 Jun 6, 2010
Plexxikon announced today the results of a Phase 1 extension study in metastatic colorectal cancer that showed clinical activity of PLX4032 as a single agent in this hard-to-treat patient population. PLX4032 is a novel, oral small molecule ...
05:00 Jun 6, 2010
LANtek, a Premier Dragon Medical partner with Nuance Communications, announces a Dragon Medical Talk Clinical Tour event to be held on June 15th, 2010 from 4-6PM at Coca-Cola Park in Allentown, PA.
05:00 Jun 6, 2010
will hold welcome parties and press conferences to greet Meg Whitman in the Central Valley, who will be there to sequester herself with former Governor Pete Wilson, GOP political insiders, and hand-picked audiences at events Sunday.
00:23 Jun 6, 2010
Pharmacyclics, Inc. today announced results from a Phase I study of its novel orally administered Bruton's tyrosine kinase inhibitor, PCI-32765, in patients with relapsed or refractory B cell non-Hodgkin's lymphoma including chronic lymphocytic ...
15:08 Jun 5, 2010
Novartis Pharmaceuticals Corporation announced today that results from a Phase II study show Afinitor® tablets is the first medication in a clinical trial to decrease the size of subependymal giant cell astrocytomas , benign brain tumors ...
14:40 Jun 5, 2010
Onyx Pharmaceuticals, Inc. today announced interim results from an ongoing Phase 2 study, known as the 004 study. Carfilzomib, a selective, next-generation proteasome inhibitor, demonstrated encouraging overall response rates , tolerability and ...
14:31 Jun 5, 2010
Poniard Pharmaceuticals, Inc. , a biopharmaceutical company focused on innovative oncology therapies, today announced the full efficacy and safety data from its Phase 3 SPEAR trial of picoplatin in the second-line treatment of small cell lung ...
13:31 Jun 5, 2010
Eminent leaders and thinkers in the cancer community came together yesterday at the 2010 American Society of Clinical Oncology annual meeting for a first-of-its-kind roundtable event. The session, sponsored by Amgen and its Breakaway from Cancer® ...
12:01 Jun 5, 2010
79838 - 79857 of 126340 Stories
<<
<
Next 20 Health News
>
>>
Search News
Daily News
